Anna M. Hall, BA
- 2Articles
- 13.3KReads1
- 2017–2018Active
- 13Collaborators
- 18Citations2
About
Anna M. Hall, BA, has published research on the use of the mixed opioid receptor antagonist naltrexone in the context of stimulant effects and attention-deficit/hyperactivity disorder (ADHD). Her work includes double-blind, placebo-controlled trials examining naltrexone's impact on stimulant-induced euphoria and its interaction with clinical benefits of stimulants in ADHD. Hall's research contributes to the neurodevelopmental psychiatry field and has appeared in Psychiatrist.com between 2017 and 2018.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
